학술논문
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
Document Type
Article
Author
Aix, S.P.; Paz-Ares, L.; Ciuleanu, T.E.; Navarro, A.; Cousin, S.; Bonanno, L.; Smit, E.F.; Chiappori, A.; Olmedo, M.E.; Horvath, I.; Grohé, C.; Farago, A.F.; López-Vilariño, J.A.; Cullell-Young, M.; Nieto, A.; Vasco, N.; Gómez, J.; Kahatt, C.; Zeaiter, A.; Carcereny, E.; Roubec, J.; Syrigos, K.; Lo, G.; Barneto, I.; Pope, A.; Sánchez, A.; Kattan, J.; Zarogoulidis, K.; Waller, C.F.; Bischoff, H.; Juan-Vidal, O.; Reinmuth, N.; Dómine, M.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, January 2023, 11(1):74-86)
Subject
Language
English
ISSN
22132619
22132600
22132600